Eisai
4523.T
#1950
Rank
HK$65.96 B
Marketcap
HK$234.02
Share price
0.09%
Change (1 day)
-36.99%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): HK$3.42 Billion

According to Eisai's latest financial reports the company's current earnings are HK$5.06 Billion. In 2023 the company made an earning of HK$4.08 Billion, an increase over its 2022 earnings that were of -HK$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$3.42 B-16.08%
2023 HK$4.08 B-2392.87%
2022 -HK$0.18 Billion-103.6%
2021 HK$4.94 B-39.52%
2020 HK$8.18 B7.3%
2019 HK$7.62 B17.23%
2018 HK$6.50 B86.06%
2017 HK$3.49 B-23.64%
2016 HK$4.57 B27.28%
2015 HK$3.59 B22.08%
2014 HK$2.94 B-46.11%
2013 HK$5.46 B-21.67%
2012 HK$6.98 B-20.72%
2011 HK$8.80 B-8.44%
2010 HK$9.61 B18.85%
2009 HK$8.09 B